Authors
Loading...
Literature review shows potential blood biomarkers improve diagnosis of Alzheimer’s disease, indicating cost-effective preclinical interventions.
Bogolepova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: